Lifecore Biomedical, Inc. (LFCR) Investor Relations Documents

Lifecore Biomedical, Inc. (LFCR) investor relations documents from the company's IR site: 1 presentation, 39 press releases; latest deck 2026-08-05. Read in-app with summaries. First-party data.

Lifecore Biomedical Investor Presentation: Lifecore Biomedical, a sterile injectable CDMO, targets 12%+ revenue CAGR and >25% Adj. EBITDA margins by 2029, driven by capacity expansion and a strong pipeline.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-05PresentationLifecore Biomedical Investor Presentation
2026-08-05Press releasePress release
2026-08-05Press releaseLifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update
2026-07-29Press releasePress release
2026-07-29Press releaseLifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026
2026-07-28Press releaseLifecore Biomedical Signs Three New Customer Agreements
2026-07-15Press releasePress release
2026-07-15Press releaseLifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-30Press releasePress release
2026-06-29Press releasePress release
2026-06-29Press releasePress release
2026-06-28Press releasePress release
2026-06-26Press releasePress release
2026-06-26Press releasePress release
2026-06-25Press releasePress release
2026-06-24Press releasePress release
2026-06-22Press releasePress release
2026-06-22Press releasePress release
2026-06-21Press releasePress release
2026-06-21Press releasePress release
2026-06-21Press releasePress release
2026-06-20Press releasePress release
2026-06-20Press releasePress release

LFCR overview · LFCR earnings · LFCR financials · LFCR KPIs · LFCR ownership · LFCR peers · LFCR filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.